Tag Archives: Saroglitazar

Cadila launches new drug for treating Diabetic Dyslipidaemia

Mumbai: Cadila Healthcare on Wednesday launched Lipaglyn (Saroglitazar), a new drug for treating Diabetic Dyslipidaemia or Hypertriglyceridemia in Type II diabetes, not controlled by statins alone. The new drug has been approved for launch in India by the Drug Controller General of India (DCGI).

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , , , , , | Leave a comment